Third Brazilian Consensus for autoantibodies screening in HEp-2 cells (ANA). Recommendations for standardization of autoantibodies screening trial in HEp-2 cells, quality control and clinical associations

Revista Brasileira de Reumatologia

Volumn 49, Issue 2, 2009, Pages 89-109

  Dellavance, Alessandra ^a,b,s   Gabriel Jr , Alexandre ^c,d   Nuccitelli, Barbara ^e   Taliberti, Ben Hur ^f,g,h   von Mühlen, Carlos Alberto ^i,j,k,l   Bichara, Carlos David Araújo ^m,n,o   dos Santos, Cláudio Henrique Ramos ^p   Bueno, Cleonice ^q   Yano, Cristiane Martinez ^r,s   Mangueira, Cristóvão Luis Pitangueira ^q,t   Carvalho, Darlene Gonçalves ^u   Cardoso, Elizângela ^v   Bonfa, Eloísa ^q,s,w   Araújo, Flávia Ikeda ^s,x   Rassi, Gustavo Gabriel ^y   Mundim, Hugo Mendonça ^z   Bendet, Izidro ^aa,ab   Rego, Jozélia ^r   dos Anjos Vieira, Lisiane Maria Enriconi ^ac,ad,ae   Andrade, Luis Eduardo Coelho ^a,af   Barbosa, Maria Ordália Ferro ^b,ag   Sugiyama, Mitiko ^ah   Santiago, Mittermayer Barreto ^v,ai,aj   Slhessarenko, Natasha ^ak,al   da Silva, Nilzio Antoônio ^q,am   Francescantonio, Paulo Luiz Carvalho ^q,r   Jarach, Renata ^s   Suda, Roberto ^an   Levy, Roger Abramino ^ao,ap,aq   Sampaio, Silvia Oliveira ^ar,as,at   Neves, Suzane Pretti Figueiredo ^{q,aa,au,av,aw}   Cruvinel, Wilson de Melo ^a,s   dos Santos, Wilton Silva ^a,ax   Nóbrega, Yanna K de M ^ay,az,ba   more..

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Fleury   (Brazil)

^c Scripps Mercy Medical Center   (United States)

^d AFIP   (Brazil)

^e Padräo Laboratório Clínico

^f Reumaklinik Aachen Germany   (Germany)

^g FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^h HC UFU   (Brazil)

ⁱ PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^j RWTH AACHEN UNIVERSITY   (Germany)

^k SCRIPPS RESEARCH INSTITUTE   (United States)

^l Metanalysis Centro de Diagnósticos Médicos   (Brazil)

^m Campus II   (Brazil)

ⁿ Laboratorio Amaral Costa   (Brazil)

^o Department of Clinical Pathology   (Brazil)

^p NewLife Comércio de Produtos Laboratoriais   (Brazil)

^q UNIVERSITY OF SÃO PAULO   (Brazil)

^r FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^s PONTIFÍCIA UNIVERSIDADE CATÓLICA DE GOIÁS   (Brazil)

^t HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^u Instituto Hermes Pardini   (Brazil)

^v Instituto Hermes Pardini ^*

^w Departamento de Blomedidna da UCG   (Brazil)

^x UCG   (Brazil)

^y Laboratório Atalaia   (Brazil)

^z Exame Medicina Laboratorial   (Brazil)

^aa INSTITUTO OSWALDO CRUZ   (Brazil)

^ab Sergio Franco Medicina Diagnóstica   (Brazil)

^ac FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^ad UNIVERSITY OF SOUTHERN SANTA CATARINA   (Brazil)

^ae UNIVERSIDADE DO VALE DO ITAJAÍ   (Brazil)

^af Laboratório Médico Santa Luzia   (Brazil)

^ag SAN FRANCISCO STATE UNIVERSITY   (United States)

^ah Jardim América Laboratories   (Brazil)

^ai UNIVERSITY OF CALGARY   (Canada)

^aj FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^ak Science Development Foundation

^al HOSPITAL SANTA IZABEL   (Brazil)

^am FEDERAL UNIVERSITY OF MATO GROSSO   (Brazil)

^an Universidade Federa de Goiás   (Brazil)

^ao Padrão Laboratório Clínico

^ap ALKA   (India)

^aq FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^ar STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^as HOSPITAL PRÓ CARDÍACO   (Brazil)

^at Division of Diagnósticos da América S A   (Brazil)

^au Immunology Section   (United States)

^av FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^aw UFMG   (Brazil)

^ax HOSPITAL UNIVERSITÁRIO DE BRASÍLIA   (Brazil)

^ay UNIVERSITY OF BRASILIA   (Brazil)

^az Centro Universitario Unieuro   (Brazil)

^ba Imunotech Sistemas Diagnósticos Importação e Exportação   (Brazil)

more..

Author keywords

Antinuclear antibodies; Autoantibodies; HEp 2 cells; Immunofluorescent

Indexed keywords

ANTINUCLEAR ANTIBODY;

ANTIBODY SCREENING; ARTICLE; AUTOIMMUNE DISEASE; BRAZIL; CLINICAL ASSESSMENT; CONSENSUS DEVELOPMENT; DATA ANALYSIS; DIAGNOSTIC VALUE; HEP 2 CELL; HISTOPATHOLOGY; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE TEST; LABORATORY DIAGNOSIS; NUCLEOLUS; PATHOLOGIST; PHYSICIAN; QUALITY CONTROL; STANDARDIZATION;

EID: 67651171558     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0482-50042009000200002     Document Type: Article

References (38)

1. Dellavance A, Andrade LEC. Como interpretar e valorizar adequadamente o teste de anticorpos antinucleo. J Bras Patol Med Lab 2007;43(3):157-68.
2. Forslid J, Heigl Z, Jonsson J, Scheynius A. The prevalence of antinuclear antibodies in healthy young persons and adults, comparing rat liver tissue sections with HEp-2 cells as antigen substrate. Clin Exp Rheumatol 1994;12(2):137-41.
3. Tan EM, Feltkamp TE, Smolen JS, Butcher B, Dawkins R, Fritzler MJ, et al. Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum1997;40(9):1601-11.
4. Leser PG, Dellavance A, Barbosa SH, Guis G, Rodrigues SH, Sato EI. Distinctive features of antinuclear antibodies observed in health and in subjects with autoimmune rheumatic disease. In: Conrad K, Bachmann MO, Chan EKL, Fritzler MJ, Humble RL, Sack U. editors. From animal models to human genetics: research on the induction and pathogenicity of autoantibodies. Dresden: Pabst 2004. 493-510.
5. Fritzler MJ, Pauls JD, Kinsella TD, Bowen TJ. Antinuclear, anticytoplasmic and anti-Sjogren's syndrome antigen A (SS-A/Ro) antibodies in female blood donors. Clin Immunol Immunopathol 1985;36:120-8.
6. Massabki PS, Accetturi C, Nishie IA, da Silva NP, Sato EI, Andrade LE. Clinical implications of autoantibodies in HIV infection. Aids 1997;11(15):1845-50.
7. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349(16):1526-33.
8. Deane PMG, Liard G, Siegel DM, Baum J. The outcome of children referred to a pediatric rheumatology clinic with a positive antinuclear antibody test but without an autoimmune disease. Pediatrics 1995;95(6):892-5.
9. Borg AA, Dawes PT, Mattey DL. Autoantibodies to nuclear lamins and to intermediate filament proteins. J Rheumatol 1993;20:1988-90.
10. Rubin RL. Autoimmune reactions induced by procainamide and hydralazine. In Kammuller M, Bloksma M, Siemen W (eds): Autoimmunity and Toxicology: Immune Dysregulation Induced by Drugs and Chemicals. Amsterdam, Elsevier 1988.
11. Amoura Z, Koutouzov S, Chabre H, Cacoub P, Amoura I, Musset L, et al. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Arthritis Rheum 2000;43(1):76-84.
12. Notman DD, Kurata N, Tan EM. Profiles of antinuclear antibodies in systemic rheumatic diseases. Ann Intern Med 1975;83(4):464-9.
13. Barcellos KS, Nonogaki S, Enokihara MM, Teixeira MS, Andrade LE. Differential expression of Ro/SSA 60 kDa and La/SSB, but not Ro/SSA 52 kDa, mRNA and protein in minor salivary glands from patients with primary Sjögren's syndrome. J Rheumatol 2007;34(6):1283-92.
14. Ochs RL, Muro Y, Si Y, Ge H, Chan EK, Tan EM. Autoantibodies to DFS 70 kd/transcription coactivator p75 in atopic dermatitis and other conditions. J Allergy Clin Immunol 2000;105(6):1211-20.
15. Andrade LEC, Chan EKL, Raska I, Peebles CL, Roos G, Tan EM. Human autoantibody to a novel protein of the nuclear coiled body: immunological characterization and cDNA cloning of p80-coilin. J Exp Med 1991;173:1407-19.
16. Lohse AW, zum Büschenfelde KH, Franz B, Kanzler S, Gerken G, Dienes HP. Characterization of the overlap syndrome of Primary Biliary Cirrhosis (PBC) and Autoimmune Hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals. Hepatology 1999;29(4):1078-84.
17. Fritzler MJ, Kinsella TD. The CREST syndrome: a distinct serologic entity with anticentromere antibodies. Am J Med 1980;69(4):520-6.
18. Göring HD, Panzner M, Lakota W, Zeiner A. Association of Scleroderma and Primary Biliary Cirrhosis - results of a systematic study on a dermatological clientele. Hautarzt 1998;49:361-66.
19. Takasaki Y, Deng JS, Tan EM. A nuclear antigen associated with cell proliferation and blast transformation. J Exp Med 1981;154:1899-909.
20. Targoff IN. Autoantibodies in polymyositis. Rheum Dis Clin North Am 1992;18:455-82.
21. Reimer G, Raska I, Tan EM, Scheer U. Human autoantibodies: probes for nucleolus structure and function. Virchows Arch B Cell Pathol Incl Mol Pathol 1987;54:131-43.
22. Agarwal N, Handa R, Acharya SK, Wali JP, Dinda AK, Aggarwal P. A study of autoimmune markers in hepatitis C infection. Indian J Med Res 2001;113:170-4.
23. Leibovitch L, George J, Levi Y, Bakimer R, Shoenfeld Y. Antiactin antibodies in sera from patients with autoimmune liver diseases and patients with carcinomas by ELISA. Immunol Lett 1995;48(2):129-32.
24. Krapf AR, Von Mühlen CA, Krapf FE, Nakamura RM, Tan EM. Atlas of immunofluorescent autoantibodies. Munich, Urban & Schwarzenberg, 1996.
25. Massabki PS, Accetturi C, Nishie IA, Silva NP, Sato EI, Andrade LE: Clinical implications of autoantibodies in HIV infection. AIDS (archive) 11:1845-50, 1997.
26. Yang Y, Fujita J, Tokuda M, Bandoh S, Ishida T. Clinical features of several connective tissue diseases with anti-Golgi antibody. Ann Rheum Dis 2001;60:986-987.
27. Eystathioy T, Chan EK, Tenenbaum SA, Keene JD, Griffith K, Fritzler MJ. A phosphorylated cytoplasmic autoantigen, GW182, associates with a unique population of human mRNAs within novel cytoplasmic speckles. Mol Biol Cell 2002;13:1338-51.
28. Bonfa E, Golombek SJ, Kaufman LD, Skelly S, Weissbach H, Brot N, et al. Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med 1987;317(5):265-71.
29. Alderuccio F, Toh BH, Barnett AJ, Pedersen JS. Identification and characterization of mitochondria autoantigens in progressive systemic sclerosis: identily with the 72,000 Dalton autoantigen in primary biliary cirrhosis. J Immunol 1986;137(6):1855-9.
30. Chou MJ, LaI MY, Lee SL. Reactivity of anti-mitochondrial antibodies in primary biliary cirrhosis and systemic sclerosis. J From Med Ass 1992;91(11):1075-80
31. Krapf A, Von Mühlen CA, Krapf F, Nakamura RMM, Tan EM. Human autoimmune diseases and autoantibodies. Bol Com Íbero-Americano Reumatol 1999;9:55-8.
32. Andrade LEC, Chan EKL, Peebles CL, Tan EM. Two major autoantigen-antibody systems of the mitotic spindle apparatus. Arthritis Rheum 1996;39:1643-53.
33. Francoeur AM, Peebles CL, Gompper PT, Tan EM. Identification of Ki (Ku, p70/p80) autoantigens and analysis of anti-Ki autoantibody reactivity. J Immunol 1986;136(5):1648-53.
34. Jarzabek-Chorzelska M, Balszczyk M, Jablonska S, Chorzelski T, Kumar V, Beutner EH. Scl -70 antibody, a specific marker of systemic sclerosis. Br J Dermatol 1986;115(4):393-401.
35. Isshi K, Hirohata S. Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus. Arthritis Rheum 1998;41(10):1819-27.
36. Carballo OG, von Mühlen CA, Nakamura R, de la Torre IG, Francescatonio PLC. Atlas Anti-Nucleocitoplasmaticos (HEp-2). Talleres Gráficos TBS, Buenos Aires, 2006.
37. von Mühlen CA, Nakamura RM. Clinical and laboratory evaluation of systemic rheumatic diseases. In McPherson & Pincus (eds): Clinical diagnosis and management by laboratory methods. Philadelphia, W.B. Saunders, 2006.
38. Dellavance A, Gabriel Jr A, Nuccitelli B, Taliberti BH, von Mühlen CA, Bichara CDA, et al. Pesquisa de auto-anticorpos em células HEp-2. Editora UCG, Goiânia, 2008.